Ovarian Cancer Risk Estimation in Patients With Pelvic Mass
Study Details
Study Description
Brief Summary
The purpose of this study is to determine whether the Risk of Ovarian Cancer Algorithm (ROMA) is effective in the determination of a woman's risk of cancer when she is scheduled to have surgery to remove a pelvic mass.
After Informed Consent is obtained, an Initial Cancer Risk Assessment will be made. A blood sample will be collected within 30 days of the surgical procedure. Results of the surgical procedure will be collected and analyzed against the CA125 and HE4 results used in the calculation of the ROMA.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Outcome Measures
Primary Outcome Measures
- 1. A statistically higher number of cancer patients are correctly assigned by the combination of Initial Cancer Risk assessment and positive ROMA test result than by Initial Cancer Risk assessment alone [Blood draw within 30 days of surgery]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Female, age ≥ 18 years
-
Adnexal mass present documented by imaging
-
Scheduled to undergo surgery based on a finding of adnexal mass (defined as a simple, complex or a solid ovarian cyst/or any mass in pelvis)
-
Able to understand and willing to provide Informed Consent
Exclusion Criteria:
-
Previous history of ovarian cancer
-
Previous history of bilateral oophorectomy
-
Currently known to be pregnant
-
Unable to provide informed consent
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Scripps Clinic Carmel Valley | San Diego | California | United States | 92130 |
2 | Women's Clinic of Northern Colorado | Fort Collins | Colorado | United States | 80524 |
3 | OB/GYN Specialists of the Palm Beaches | Jupiter | Florida | United States | 33458 |
4 | University of South Florida Medical Center | Tampa | Florida | United States | 33606 |
5 | Woman's Hospital | Baton Rouge | Louisiana | United States | 70815 |
6 | Weill Medical College of Cornell University | New York | New York | United States | 10021 |
7 | New Hanover Regional Medical Center | Wilmington | North Carolina | United States | 28402 |
8 | University of Oklahoma Health Sciences Center | Oklahoma City | Oklahoma | United States | 73110 |
9 | Geisinger Medical Center | Danville | Pennsylvania | United States | 17822 |
10 | Women & Infants Hospital Rhode Island | Providence | Rhode Island | United States | 02905 |
11 | Chattanooga GYN-ONCOLOGY | Chattanooga | Tennessee | United States | 37403 |
12 | Jackson Clinic | Jackson | Tennessee | United States | 38305 |
13 | Adams Patterson Gynecology & Obstetrics | Memphis | Tennessee | United States | 38120 |
Sponsors and Collaborators
- Fujirebio Diagnostics, Inc.
- Advanced Clinical Research Services, LLC
- ReSearch Pharmaceutical Services, Inc.
Investigators
- Principal Investigator: Richard Moore, MD, FACOG, FACS, Women & Infants Hospital Rhode Island
Study Documents (Full-Text)
None provided.More Information
Additional Information:
Publications
None provided.- FDI-15